References
- FUNAE, Y. and IMAOKA, S., 1985, Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochimica et Biophysica Acta, 842, 119–132.
- FUNAE, Y. and IMAOKA S., 1993, Cytochrome P450 in rodents. In I. B. Shenkmann and H. Greim (eds), Cytochromes P450 (Berlin: Springer), pp. 222–238.
- GOULD, B. J., AMOATH, A. G. and PARKE, D. V., 1986, Stereoselective pharmacokinetics of perhexiline. Xenobiotica, 16, 491–502.
- HIROTA, T., NAKAMURA, A., SUGIHARA, K. and MORINO, A., 1997, Pharmacokinetics of (± )-4-diethylamino-1,1-dimethybut-2-yn- 1-y1 2-cyclohexy1-2-hydroxy-2-phenylacetate monohydro - chloride monohydrate: the metabolism of NS-21 in rats and dogs. Arzneimittel Forschung Drug Research, 47, 175–181.
- KIMURA, Y., FUKUI, H., HAMADA, K., OGASAWARA, T., YAMAZAKI, C., UKAI, Y., YOSHIKUNI, Y. and KIMURA, K., 1997, Effect of the anticholinergic drug with calcium antagonistic activity, (± )-4-diethylamino-1,1-dimethybut-2-yn- 1-y1 2-cyclohexy1-2-hydroxy-2-phenylacetate monohydro - chloride monohydrate, on lower urinary tract function in decerebrated dogs. Arzneimittel Forschung Drug Research, 47, 182–189.
- KOBAYASHI, S., MURRAY, S., WATSON, D., SERARDIC, D., DAvrEs, D. A. and BOOBIS, A. R., 1989, The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology, 38, 2795–2799.
- LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J. 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
- NAKAMURA, A., HIROTA, T., SUGIHARA, K. and MORINO, A., 1997a, Pharmacokinetics of (± )-4-diethylamino-1,1-dimethybut-2-yn- 1-y1 2-cyclohexy1-2-hydroxy-2-phenylacetate monohydro - chloride monohydrate: plasma concentrations of the unchanged drug and its deethylated metabolite after administration of NS-21 to rats, dogs and monkeys. Arzneimittel Forschung Drug Research, 47, 169–174.
- NAKAMURA, A., SUGIHARA, K., HIROTA, T., Ezumi, Y., TAKAICHI, M. and MORINO, A., 1997b, Pharmacokinetics of (± )-4-diethylamino-1,1-dimethybut-2-yn-1-y1 2-cyclohexy1-2-hydroxy-2-phenylacetate monohydrochloride monohydrate: absorption, distribution and excretion of C-labeled compound in rats and dogs. Arzneimittel Forschung Drug Research, 47, 151–159.
- PESSAYRE, D., DESCATOIRE, V., KONSTANTINOVA -MITCHEVA, M., WANDSHEER, J. C., COBERT, B., LEVEL, R., BENHAMOU, J. P., JAOUEN, M. and MANSUY, D., 1981, Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P450. Biochemical Pharmacology, 30, 553–564.
- RODRIGUES, A. D. and WONG, S. L., 1997, Application of human liver microsomes in metabolism-based drug—drug interactions: in vitro—in vivo correlations and the Abbott Laboratories experience. In A. P. Li (ed.), Drug—Drug Interactions (San Diego: Academic Press), pp. 65–101.
- SASAKI, Y., HAMADA, K., YAMAZAKI, C., SETO, T., KIMURA, Y., UKAI, Y., YOSHIKUNI, Y. and KIMURA, K., 1997, Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency. International Journal of Urology, 4, 401–406.
- YASUKOCHI, Y. and MASTERS, B. S. S., 1976, Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. Journal of Biological Chemistry, 251, 5337–5344.